Keith Wayne Ward, Chief Development Officer at REATA PHARMACEUTICALS INC (RETA), sold 8,300 shares at $53.71 ($448K) on 2019-01-02, disclosed to the SEC on 2019-01-03.
Open-market sale of $448k RETA by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.71 | 2,830 | $152K | 33.9% |
| 2 | $53.71 | 2,830 | $152K | 33.9% |
| 3 | $54.58 | 1,320 | $72K | 16.1% |
| 4 | $54.58 | 1,320 | $72K | 16.1% |
| Total | $53.99 avg | 8,300 | $448K | 100% |
| Filing → |
| RETA | SELL | 2018-11-08 | $636K | — | Filing → |
| RETA | SELL | 2018-11-01 | $283K | — | Filing → |
| RETA | SELL | 2018-10-24 | $813K | — | Filing → |